• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MINN FG GATEWAY OTW JP 2.50MM X 9MM; CATHETER, BALLOON TYPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MINN FG GATEWAY OTW JP 2.50MM X 9MM; CATHETER, BALLOON TYPE Back to Search Results
Catalog Number M0032072009250
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Hematoma (1884); Thrombosis (2100); Coma (2417); Vascular Dissection (3160)
Event Date 01/24/2017
Event Type  Death  
Manufacturer Narrative
This is the 3rd of 5 reports.
 
Event Description
It was reported that a patient was presented in a life-threatening condition with a basilar thrombotic stroke and neurological deficit.Access to the clot was limited to the right vertebral artery (va) that presented a critical stenosis of the va-distal v4 segment.Left vertebral artery was occluded and not accessible.Angioplasty with the subject balloon catheter of the stenosis of va-v4 segment led to dissection resulting in hematoma and occlusion.Medical intervention in order to restore blood flow through the occluded va- v4 segment by angioplasty was performed without success.Then, stenting of the va-v4 segment with a first stent was performed.However, the distal stent tines did not open properly even with additional angioplasty procedure.Blood flow was not restored.A second stent was attempted to be implanted but could not be deployed beyond the poorly opened distal tines of the first deployed stent.A third stent was deployed more distally in the basilar artery and overlapping the original stent.The stent was only placed with great difficulty through the first stent.There was some bending of the hypotube but it did not render the stent unusable.Blood flow was not restored and injection of platelet aggregation inhibitor into the occluded vessel as well as additional angioplasty was performed.The stent tines and the stents were eventually correctly opened but blood flow was not restored.The physician reported that he would have strongly preferred to use a different size balloon catheter but due to the emergency nature of the procedure, a more appropriately sized balloon was not available.Two days post procedure, the patient was determined to be in "coma" and pronounced dead shortly after.In the physician¿s opinion, ¿the outcome prognosis without the intervention was poor, with death as a possibility.The procedure did not help the patient and may have made him worse.The patient's death is not specifically related to any of the devices¿.
 
Manufacturer Narrative
The device history record (dhr) review confirms that the device met all material, assembly and performance specifications.The subject device was not returned for analysis; therefore, physical as well as a functional testing could not be performed.However, dissection, patient outcome of death, patient hematoma, patient complications, patient thrombosis are known risks associated with endovascular procedures and noted as such in the device directions for use (dfu).Therefore, an assignable cause of anticipated procedural complication was assigned to this event.
 
Event Description
It was reported that a patient was presented in a life-threatening condition with a basilar thrombotic stroke and neurological deficit.Access to the clot was limited to the right vertebral artery (va) that presented a critical stenosis of the va-distal v4 segment.Left vertebral artery was occluded and not accessible.Angioplasty with the subject balloon catheter of the stenosis of va-v4 segment led to dissection resulting in hematoma and occlusion.Medical intervention in order to restore blood flow through the occluded va- v4 segment by angioplasty was performed without success.Then, stenting of the va-v4 segment with a first stent was performed.However, the distal stent tines did not open properly even with additional angioplasty procedure.Blood flow was not restored.A second stent was attempted to be implanted but could not be deployed beyond the poorly opened distal tines of the first deployed stent.A third stent was deployed more distally in the basilar artery and overlapping the original stent.The stent was only placed with great difficulty through the first stent.There was some bending of the hypotube but it did not render the stent unusable.Blood flow was not restored and injection of platelet aggregation inhibitor into the occluded vessel as well as additional angioplasty was performed.The stent tines and the stents were eventually correctly opened but blood flow was not restored.The physician reported that he would have strongly preferred to use a different size balloon catheter but due to the emergency nature of the procedure, a more appropriately sized balloon was not available.Two days post procedure, the patient was determined to be in "coma" and pronounced dead shortly after.In the physician¿s opinion, ¿the outcome prognosis without the intervention was poor, with death as a possibility.The procedure did not help the patient and may have made him worse.The patient's death is not specifically related to any of the devices¿.
 
Manufacturer Narrative
The device history record (dhr) review confirms that the device met all material, assembly and performance specifications.The subject device was not returned for analysis; therefore, physical as well as a functional testing could not be performed.However, dissection, patient outcome of death, patient complications, patient thrombosis are known risks associated with endovascular procedures and noted as such in the device directions for use (dfu).Therefore, an assignable cause of anticipated procedural complication was assigned to this event.
 
Event Description
It was reported that a patient was presented in a life-threatening condition with a basilar thrombotic stroke and neurological deficit.Access to the clot was limited to the right vertebral artery (va) that presented a critical stenosis of the va-distal v4 segment.Left vertebral artery was occluded and not accessible.Angioplasty with the subject balloon catheter of the stenosis of va-v4 segment led to dissection resulting in hematoma and occlusion.Medical intervention in order to restore blood flow through the occluded va- v4 segment by angioplasty was performed without success.Then, stenting of the va-v4 segment with a first stent was performed.However, the distal stent tines did not open properly even with additional angioplasty procedure.Blood flow was not restored.A second stent was attempted to be implanted but could not be deployed beyond the poorly opened distal tines of the first deployed stent.A third stent was deployed more distally in the basilar artery and overlapping the original stent.The stent was only placed with great difficulty through the first stent.There was some bending of the hypotube but it did not render the stent unusable.Blood flow was not restored and injection of platelet aggregation inhibitor into the occluded vessel as well as additional angioplasty was performed.The stent tines and the stents were eventually correctly opened but blood flow was not restored.The physician reported that he would have strongly preferred to use a different size balloon catheter but due to the emergency nature of the procedure, a more appropriately sized balloon was not available.Two days post procedure, the patient was determined to be in "coma" and pronounced dead shortly after.In the physician¿s opinion, ¿the outcome prognosis without the intervention was poor, with death as a possibility.The procedure did not help the patient and may have made him worse.The patient's death is not specifically related to any of the devices¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FG GATEWAY OTW JP 2.50MM X 9MM
Type of Device
CATHETER, BALLOON TYPE
Manufacturer (Section D)
BOSTON SCIENTIFIC - MINN
one scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC - MINN
one scimed place
maple grove MN 55311
Manufacturer Contact
michael reddick
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key6354692
MDR Text Key68186794
Report Number0002134265-2017-30002
Device Sequence Number1
Product Code GBA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H050001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/19/2017
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received02/23/2017
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2019
Device Catalogue NumberM0032072009250
Device Lot Number19332937
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/20/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/08/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
1 GATEWAY BALLOON CATHETER (STRYKER); 3 WINGSPAN STENTS (STRYKER)
Patient Outcome(s) Death; Other; Required Intervention;
Patient Age71 YR
-
-